Genetic Manipulation of the Endocannabinoid System

Area of Science:

• Neuroscience
• Pharmacology
• Genetics

Background:

• The endocannabinoid system's functions are extensively studied using genetically modified mouse models.
• Early gene deletions for cannabinoid receptor 1 (CB1) and CB2, and fatty acid amide hydrolase (FAAH) provided foundational insights.

Purpose of the Study:

• To provide a comprehensive overview of available genetic models for the endocannabinoid system.
• To summarize key discoveries enabled by these genetic mouse models.

Main Methods:

• Utilizing transgenic and targeted knockout mouse models.
• Development of conditional mutant mice, including "floxed" alleles and re-expression models, primarily for CB1.
• Integration of viral expression systems with genetic models.

Main Results:

• Elucidation of endocannabinoids' role as retrograde transmitters in the central nervous system (CNS).
• Discovery of unexpected endocannabinoid functions in peripheral tissues like skin, bone, and liver.
• Deciphering CB1 receptor functions in specific neuronal circuits and cell populations through conditional mutants.

Conclusions:

• A wide array of genetic models now exists for nearly every component of the endocannabinoid system.
• These models are crucial for dissecting complex physiological and pathophysiological roles of endocannabinoids.
• Future research can leverage these advanced models to further explore endocannabinoid signaling and therapeutic potential.